BioNTech SE, US09075V1026

BioNTech SE stock heads into the open after a Nasdaq rally

Published on 09/22/2026 at 08:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 21, 2026, BioNTech SE stock traded against a Nasdaq Composite gain of 2.26 percent as US equities rallied on technology strength and lower oil prices.

BioNTech SE, US09075V1026, Illustration mit AI erstellt.
BioNTech SE, US09075V1026, Illustration mit AI erstellt.

BioNTech SE stock closed on the Nasdaq on September 21, 2026, after the US market advanced, but the available dated market data do not provide a verified BioNTech closing price or daily percentage change for that session.

September 21, 2026 market context

BioNTech SE (ISIN US09075V1026) entered the session against a Nasdaq Composite close of 27,122.09, up 2.26 percent on September 21, 2026. US exchange volume reached 16.5 billion shares, compared with a 20-session average of 16.2 billion shares, according to The Straits Times.

The market wrap attributed the broad advance to renewed artificial-intelligence optimism, retreating Treasury yields and falling crude prices, with the Nasdaq reaching a record close on September 21, 2026.

September 22, 2026 outlook

The US session begins ahead of the open on September 22, 2026. The market backdrop includes the Nasdaq Composite record close and lower oil prices, factors relevant to biotechnology shares through broader risk appetite and financing conditions.

Disclaimer...

en | US09075V1026 | BIONTECH SE | boerse | 70151862 | bgmi